May 2022 HCCI Research Highlights

HCCI’s data users and staff use our multi-payer, longitudinal commercial claims dataset to study some of the most pressing issues in the U.S. health care system. Here we highlight some recent research using HCCI data:

COVID Tests Cost $0 for Most People in 2020 | HCCI

We used HCCI’s unique commercial claims dataset to analyze claims from over 19 million COVID-19 tests across 50 states and Washington DC in 2020.

https://healthcostinstitute.org/hcci-research/covid-tests-cost-0-for-most-people-in-2020

Physician Prices and Low-Value Services: Evidence From General Internal Medicine | AJMC

This study, using HCCI data, found extensive variation in general internal medicine physician prices and that high-priced physicians provided fewer low-value services but had higher spending on these services.

https://www.ajmc.com/view/physician-prices-and-low-value-services-evidence-from-general-internal-medicine

Opioid Prescriptions, Radiography, and Costs for Self-Limited “One-and- Done” Lower Back Pain Visits in a Commercially Insured Population | UW CHWS

Enter some description here…

https://familymedicine.uw.edu/chws/publications/opioid-prescriptions-radiography-and-costs-for-self-limited-one-and-done-lower-back-pain-visits-in-a-commercially-insured-population/

Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019 | JAMA Network

This cross-sectional study uses HCCI data to compare the prices that private insurers vs Medicare paid for hemodialysis in the US from 2012 to 2019.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789455